| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |